We are happy to announce that Friso Reitsma has joined our Rotterdam office as a Consultant! Friso graduated with a master’s degree in Health Economics, Policy and Law at the Erasmus University in Rotterdam and holds two bachelor’s degrees from the University of Groningen – one in Psychology and one in Business Administration. He has
We did it again! This year, we again ranked amongst the fastest growing companies in the Netherlands. We are proud that we have continued our growth and we wantto thank our clients and our amazing team for making this wonderful achievement possible #proud #FDGazelle2020 #Ingresssteam #HEOR
We are very pleased to announce that Maria will join the Cytel health economics team! With her wealth of experience in global SLR’s she will further strengthen the joint capabilities of Cytel and Ingress in this field. As a Senior Director HEOR she will lead projects from the UK. We look forward to closely work
In oncology, we increasingly notice an introduction of novel oral treatments. While this is certainly more convenient for patients and the benefits of this are great, patients’ non-adherence is now becoming a new challenge in oncology. Over recent years, Ingress-Health has gained extensive knowledge in this particular topic. Please find below our recording of the
Please join our colleagues at Cytel for this webinar series and join experts as they embark on two pilot projects on head-to-head comparisons using real world data. These projects in oncology and cardiovascular will occur in real time across the series. You will see the data and analytical challenges faced during the projects, and how these challenges
At Ingress-health, we’re committed to supporting a diverse workplace. This month and every month, we stand for equality and advocate for our #LGBTQ+ colleagues, friends and family. Join us in celebrating #PrideMonth by creating an inclusive environment for all. #LoveisLove #Equality #Diversity #Inclusion
Please join our Webinare the 23rd of June 2020, free of charge! If you would like to participate, please send confirmation to email@example.com.
In our recent publication, the Ingress-Health RWE team, together with clinical experts, analyzed a big German claims dataset with >8 million insured to explore unmet needs in patients with Inflammatory Bowel disease not treated with biologics. The team identified a substantial percentage of patients who suffer from active disease and/or steroid dependency, and the majority
According to the World Health Organization (WHO), 235 million people suffer from asthma worldwide. To learn more about potential barriers to therapy adherence in asthma, click here
Ingress-health B.V. and Indivumed GmbH announced today the launch of an exclusive partnership on real-world evidence (RWE) studies in oncology. Click here to find out more!